Reference number : 1480-2020-2021-Qrt1-0000183, amendment number : 1, agreement type : C, recipient legal name : CISSS de la Gaspésie | CISSS de la Gaspésie, recipient country : CA, recipient province : QC, recipient city : Gaspé | Gaspé, recipient postal code : G4X2W5, program name english : Health Promotion and Chronic Disease Prevention, program name french : Promotion de la santé et prévention des maladies chroniques, program purpose english : The Health Promotion and Chronic Disease Prevention program promotes the health and well-being of Canadians of all ages by supporting community-based projects which address the root causes of health inequalities, and the common risk and protective factors that are important to preventing chronic disease, and conduct public health research and surveillance., program purpose french : Le programme de Promotion de la santé et prévention de maladies chroniques promeut la santé et le bien-être des Canadiens et des Canadiennes de tous âges en appuyant les projets communautaires qui s’attaquent aux causes profondes des inégalités en matière de santé ainsi qu’aux facteurs de risque ou de protection qui sont essentiels à la prévention des maladies chroniques, et effectuer de la recherche et de la surveillance en santé publique., agreement title english : 1718-HQ-000551, agreement title french : 1718-HQ-000551, agreement number : 1718-HQ-000551, agreement value : 274540.0, agreement start date : 2017-04-01, agreement end date : 2025-03-31, description english : P000396, description french : P000396, expected results english : Not Available, expected results french : Non Disponible, additional information english : Belated Reporting (Funding of $274,540.00 actually awarded in Fiscal Year 2019-2020, Quarter 4), additional information french : Rapports tardifs (Financement de $274,540.00 attribué dans l'année financière 2019-2020, Trimestre 4), owner organization : phac-aspc, owner organization title : Public Health Agency of Canada | Agence de la santé publique du Canada